Inhibition of 11β-Hydroxysteroid dehydrogenase-1 with AZD4017 in patients with nonalcoholic steatohepatitis or nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled, phase II study

Yogesh Yadav, Kelly Dunagan, Rachita Khot, Sudhakar K. Venkatesh, John Port, Alfonso Galderisi, Claudio Cobelli, Craig Wegner, Ananda Basu, Rickey Carter, Rita Basu

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Inhibition of 11β-Hydroxysteroid dehydrogenase-1 with AZD4017 in patients with nonalcoholic steatohepatitis or nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled, phase II study'. Together they form a unique fingerprint.

Medicine & Life Sciences